124 related articles for article (PubMed ID: 16685155)
1. [Home care of hematological malignancies].
Urabe A
Gan To Kagaku Ryoho; 2006 May; 33(5):599-601. PubMed ID: 16685155
[TBL] [Abstract][Full Text] [Related]
2. Role of granulocyte colony stimulating factor (G-CSF) in chemotherapy induced neutropenia.
Ghalaut PS; Sen R; Dixit G
J Assoc Physicians India; 2008 Dec; 56():942-4. PubMed ID: 19322972
[TBL] [Abstract][Full Text] [Related]
3. CD34+ dose-driven administration of granulocyte colony-stimulating factor after high-dose chemotherapy in lymphoma patients.
Todisco E; Castagna L; Sarina B; Mazza R; Magagnoli M; Balzarotti M; Nozza A; Siracusano L; Timofeeva I; Anastasia A; Demarco M; Santoro A
Eur J Haematol; 2007 Feb; 78(2):111-6. PubMed ID: 17313558
[TBL] [Abstract][Full Text] [Related]
4. Should prophylactic granulocyte-colony stimulating factor be used in multiple myeloma patients developing neutropenia under lenalidomide-based therapy?
Mateos MV; García-Sanz R; Colado E; Olazábal J; San-Miguel J
Br J Haematol; 2008 Feb; 140(3):324-6. PubMed ID: 18067473
[TBL] [Abstract][Full Text] [Related]
5. Granulocyte-colony stimulating factor for the treatment of ritodrine-induced neutropenia.
Kikkawa M; Matsubara S; Takatoku M; Kuwata T; Ohkuchi A; Izumi A; Watanabe T; Suzuki M
J Obstet Gynaecol Res; 2008 Apr; 34(2):286-90. PubMed ID: 18412800
[TBL] [Abstract][Full Text] [Related]
6. 2nd International Congress on Leukemia, Lymphoma and Myeloma.
Arat M; Ozsan GH; Yenerel MN; Cetin M; Ozcan M
Expert Rev Hematol; 2009 Oct; 2(5):509-12. PubMed ID: 21083016
[TBL] [Abstract][Full Text] [Related]
7. [The use of G-CSF in hematological disorders].
Dan K
Rinsho Ketsueki; 1997 May; 38(5):367-70. PubMed ID: 9194376
[No Abstract] [Full Text] [Related]
8. Granulocytic growth factors and cancer-related neutropenia: limited effects.
Prescrire Int; 2006 Oct; 15(85):189-91. PubMed ID: 17128529
[TBL] [Abstract][Full Text] [Related]
9. Current status of growth factors in the treatment of acute myeloid and lymphoblastic leukemia.
Ottmann OG; Bug G; Krauter J
Semin Hematol; 2007 Jul; 44(3):183-92. PubMed ID: 17631182
[TBL] [Abstract][Full Text] [Related]
10. Peripheral blood progenitor cell collection without close monitoring of peripheral blood CD34+ cells: A feasible strategy for multiple myeloma or pre-treated Non-Hodgkin's Lymphoma patients mobilized with low-dose cyclophosphamide plus G-CSF.
Callera F; Cavenaghi L; de Melo CM
Transfus Apher Sci; 2009 Apr; 40(2):91-5. PubMed ID: 19233728
[TBL] [Abstract][Full Text] [Related]
11. [Essentials for transition of palliative care patients to palliative home care and for management of their cancer pain].
Koshikawa T; Shimoyama N
Gan To Kagaku Ryoho; 2006 May; 33(5):611-5. PubMed ID: 16685158
[TBL] [Abstract][Full Text] [Related]
12. [Hematological malignancies in congenital neutropenia].
Okada S; Nakamura K; Kobayashi M
Rinsho Ketsueki; 2010 Jul; 51(7):553-8. PubMed ID: 20693776
[No Abstract] [Full Text] [Related]
13. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
Hershman D; Neugut AI; Jacobson JS; Wang J; Tsai WY; McBride R; Bennett CL; Grann VR
J Natl Cancer Inst; 2007 Feb; 99(3):196-205. PubMed ID: 17284714
[TBL] [Abstract][Full Text] [Related]
14. Granulocyte colony-stimulating factor-based stem cell mobilization in patients with sickle cell disease.
Rosenbaum C; Peace D; Rich E; Van Besien K
Biol Blood Marrow Transplant; 2008 Jun; 14(6):719-23. PubMed ID: 18489998
[TBL] [Abstract][Full Text] [Related]
15. [Successful treatment with G-CSF and corticosteroid of adult idiopathic autoimmune neutropenia presenting as recurrent enterocolitis].
Fujimi A; Matsunaga T; Ohnishi R; Takemoto N; Tanaka I; Akiyama T; Sato T; Morii K; Terui T; Kogawa K; Kato J; Hirayama M; Ohmi N; Sakamaki S; Niitsu Y
Rinsho Ketsueki; 2002 Nov; 43(11):998-1003. PubMed ID: 12508486
[TBL] [Abstract][Full Text] [Related]
16. [Current status and future perspective of new drugs for hematological malignancies in Japan].
Ogura M
Rinsho Ketsueki; 2007 Oct; 48(10):1442-52. PubMed ID: 17933133
[No Abstract] [Full Text] [Related]
17. The effect of granulocyte colony-stimulating factor (G-CSF) on the activity of granulocyte enzymes in children with cancer who developed neutropenia after chemotherapy.
Czygier M; Dakowicz L; Szmitkowski M
Adv Med Sci; 2008; 53(2):278-82. PubMed ID: 18614436
[TBL] [Abstract][Full Text] [Related]
18. Dose and outcome: the hurdle of neutropenia (Review).
Marangolo M; Bengala C; Conte PF; Danova M; Pronzato P; Rosti G; Sagrada P
Oncol Rep; 2006 Aug; 16(2):233-48. PubMed ID: 16820898
[TBL] [Abstract][Full Text] [Related]
19. Review of the value of colony stimulating factors for prophylaxis of febrile neutropenic episodes in adult patients treated for haematological malignancies.
Levenga TH; Timmer-Bonte JN
Br J Haematol; 2007 Jul; 138(2):146-52. PubMed ID: 17593021
[TBL] [Abstract][Full Text] [Related]
20. [Effectiveness of Leukostim, a Russian preparation of granulocyte colony-stimulating factor, in the treatment of chemotherapy-induced neutropenia in patients with malignant tumors].
Korman DB; Boronovskaia LE; Maslova IA; Andreeva EV; Seregina GV
Vopr Onkol; 2008; 54(5):639-42. PubMed ID: 19069482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
